Transforming Big Data into Cancer-Relevant Insight: An Initial, Multi-Tier Approach to Assess Reproducibility and

    Insights

    The Cancer Target Discovery and Development (CTD(2)) Network developed a framework to validate big data findings for cancer drug discovery. This approach ensures reliable evidence for novel therapeutic and biomarker strategies.

    Area of Science:

    • Oncology
    • Bioinformatics
    • Translational Medicine

    Background:

    • The Cancer Target Discovery and Development (CTD(2)) Network aims to translate big data into cancer therapeutics.
    • A key challenge identified was defining sufficient evidence for biological and clinical findings.

    Purpose of the Study:

    • To address the need for robust validation of discoveries from large-scale data analysis.
    • To propose a framework for substantiating the relevance and reproducibility of collaborative research findings.

    Main Methods:

    • The CTD(2) Network implemented a multi-tier framework.
    • This framework was designed to evaluate biological and biomedical relevance.
    • Reproducibility of data and insights was a key consideration.

    Main Results:

    • A framework was established to support and confirm discoveries from big data analysis.
    • The framework aims to enhance the reliability of novel pharmacologic targets, lead compounds, and biomarkers.
    • The approach facilitates community discussion on validating research findings.

    Conclusions:

    • The proposed multi-tier framework can guide the scientific community in validating cancer research.
    • It supports the development of novel therapeutic and biomarker strategies for cancer treatment.
    • This systematic approach is crucial for translating big data into improved patient outcomes.

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    812
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    6.3K
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    55.4K
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    7.3K